Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001609351-18-000028)

Filing Details

Accession Number:: 0001609351-18-000028
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-16 17:49:03
Reporting Period:: 2017-10-12

Accepted Time:: 2018-04-16 17:49:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609351	Spark Therapeutics Inc.	ONCE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202294	Elliot Sigal	C/O Spark Therapeutics, Inc. 3737 Market Street, Suite 1300 Philadelphia PA 19104		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-12	29	$90.75	11,243	No	4	P	Direct
Common Stock	Disposition	2017-11-28	29	$72.43	11,214	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	S	Direct

Footnotes

Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The transactions were made by the investment advisor in contradiction of the Reporting Person's instructions and without the Reporting Person's approval.